vs
Industrial Logistics Properties Trust(ILPT)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
Industrial Logistics Properties Trust的季度营收约是RIGEL PHARMACEUTICALS INC的1.6倍($113.9M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -1.6%,领先385.6%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs 3.1%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 0.7%)
Industrial Logistics Properties Trust是一家专注于工业与物流地产的房地产投资信托,主要在美国境内持有及运营配送中心、仓储设施与最后一公里配送物业,为电商、零售、制造及供应链运营企业提供仓储及物流运营相关配套服务。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
ILPT vs RIGL — 直观对比
营收规模更大
ILPT
是对方的1.6倍
$69.8M
营收增速更快
RIGL
高出18.1%
3.1%
净利率更高
RIGL
高出385.6%
-1.6%
两年增速更快
RIGL
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $113.9M | $69.8M |
| 净利润 | $-1.8M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -22.1% | 33.2% |
| 净利率 | -1.6% | 384.0% |
| 营收同比 | 3.1% | 21.2% |
| 净利润同比 | 92.6% | 1769.2% |
| 每股收益(稀释后) | $-0.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ILPT
RIGL
| Q4 25 | $113.9M | $69.8M | ||
| Q3 25 | $110.9M | $69.5M | ||
| Q2 25 | $112.1M | $101.7M | ||
| Q1 25 | $111.9M | $53.3M | ||
| Q4 24 | $110.5M | $57.6M | ||
| Q3 24 | $108.9M | $55.3M | ||
| Q2 24 | $110.6M | $36.8M | ||
| Q1 24 | $112.2M | $29.5M |
净利润
ILPT
RIGL
| Q4 25 | $-1.8M | $268.1M | ||
| Q3 25 | $-21.6M | $27.9M | ||
| Q2 25 | $-21.3M | $59.6M | ||
| Q1 25 | $-21.5M | $11.4M | ||
| Q4 24 | $-24.1M | $14.3M | ||
| Q3 24 | $-25.0M | $12.4M | ||
| Q2 24 | $-23.2M | $-1.0M | ||
| Q1 24 | $-23.4M | $-8.2M |
毛利率
ILPT
RIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率
ILPT
RIGL
| Q4 25 | -22.1% | 33.2% | ||
| Q3 25 | -29.4% | 40.9% | ||
| Q2 25 | -30.8% | 60.1% | ||
| Q1 25 | -26.9% | 23.9% | ||
| Q4 24 | -31.1% | 28.9% | ||
| Q3 24 | -33.5% | 25.4% | ||
| Q2 24 | -32.4% | 1.2% | ||
| Q1 24 | -31.7% | -23.6% |
净利率
ILPT
RIGL
| Q4 25 | -1.6% | 384.0% | ||
| Q3 25 | -19.4% | 40.2% | ||
| Q2 25 | -19.0% | 58.6% | ||
| Q1 25 | -19.2% | 21.5% | ||
| Q4 24 | -21.8% | 24.9% | ||
| Q3 24 | -22.9% | 22.5% | ||
| Q2 24 | -20.9% | -2.8% | ||
| Q1 24 | -20.9% | -27.9% |
每股收益(稀释后)
ILPT
RIGL
| Q4 25 | $-0.02 | $14.11 | ||
| Q3 25 | $-0.33 | $1.46 | ||
| Q2 25 | $-0.32 | $3.28 | ||
| Q1 25 | $-0.33 | $0.63 | ||
| Q4 24 | $-0.37 | $0.82 | ||
| Q3 24 | $-0.38 | $0.70 | ||
| Q2 24 | $-0.35 | $-0.06 | ||
| Q1 24 | $-0.36 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $94.8M | $155.0M |
| 总债务越低越好 | $4.2B | $52.5M |
| 股东权益账面价值 | $489.7M | $391.5M |
| 总资产 | $5.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 8.56× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
ILPT
RIGL
| Q4 25 | $94.8M | $155.0M | ||
| Q3 25 | $83.2M | $137.1M | ||
| Q2 25 | $58.6M | $108.4M | ||
| Q1 25 | $108.0M | $77.1M | ||
| Q4 24 | $131.7M | $77.3M | ||
| Q3 24 | $153.9M | $61.1M | ||
| Q2 24 | $146.2M | $49.1M | ||
| Q1 24 | $128.4M | $49.5M |
总债务
ILPT
RIGL
| Q4 25 | $4.2B | $52.5M | ||
| Q3 25 | $4.2B | $60.0M | ||
| Q2 25 | $4.2B | $60.0M | ||
| Q1 25 | $4.3B | $60.0M | ||
| Q4 24 | $4.3B | $60.0M | ||
| Q3 24 | $4.3B | $60.0M | ||
| Q2 24 | $4.3B | $60.0M | ||
| Q1 24 | $4.3B | $60.0M |
股东权益
ILPT
RIGL
| Q4 25 | $489.7M | $391.5M | ||
| Q3 25 | $494.1M | $117.6M | ||
| Q2 25 | $519.1M | $81.9M | ||
| Q1 25 | $539.5M | $18.6M | ||
| Q4 24 | $562.0M | $3.3M | ||
| Q3 24 | $585.9M | $-14.6M | ||
| Q2 24 | $618.3M | $-29.9M | ||
| Q1 24 | $643.2M | $-31.7M |
总资产
ILPT
RIGL
| Q4 25 | $5.2B | $513.6M | ||
| Q3 25 | $5.2B | $242.5M | ||
| Q2 25 | $5.2B | $206.7M | ||
| Q1 25 | $5.4B | $176.0M | ||
| Q4 24 | $5.4B | $164.0M | ||
| Q3 24 | $5.5B | $139.4M | ||
| Q2 24 | $5.5B | $128.4M | ||
| Q1 24 | $5.5B | $126.5M |
负债/权益比
ILPT
RIGL
| Q4 25 | 8.56× | 0.13× | ||
| Q3 25 | 8.49× | 0.51× | ||
| Q2 25 | 8.09× | 0.73× | ||
| Q1 25 | 7.96× | 3.23× | ||
| Q4 24 | 7.65× | 18.25× | ||
| Q3 24 | 7.35× | — | ||
| Q2 24 | 6.96× | — | ||
| Q1 24 | 6.70× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $60.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $42.0M | — |
| 自由现金流率自由现金流/营收 | 36.9% | — |
| 资本支出强度资本支出/营收 | 16.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $79.8M | — |
8季度趋势,按日历期对齐
经营现金流
ILPT
RIGL
| Q4 25 | $60.7M | $22.0M | ||
| Q3 25 | $22.7M | $24.0M | ||
| Q2 25 | $18.4M | $30.5M | ||
| Q1 25 | $11.4M | $-893.0K | ||
| Q4 24 | $2.0M | $14.5M | ||
| Q3 24 | $-3.4M | $21.7M | ||
| Q2 24 | $10.8M | $302.0K | ||
| Q1 24 | $8.0M | $-5.0M |
自由现金流
ILPT
RIGL
| Q4 25 | $42.0M | — | ||
| Q3 25 | $17.6M | — | ||
| Q2 25 | $15.2M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $-3.7M | — | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $9.4M | — | ||
| Q1 24 | $5.9M | — |
自由现金流率
ILPT
RIGL
| Q4 25 | 36.9% | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 13.5% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | -3.4% | — | ||
| Q3 24 | -5.5% | — | ||
| Q2 24 | 8.5% | — | ||
| Q1 24 | 5.2% | — |
资本支出强度
ILPT
RIGL
| Q4 25 | 16.4% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 1.9% | — |
现金转化率
ILPT
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图